Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vero Cell-Derived H5N1 Vaccine Prime-Boost Study
NCT00895544Phase 2Completed
- Sponsor
- Resilience Government Services
- Start
- May 2009
- Primary completion
- Oct 2010
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 2 trial of inactivated influenza vaccine (vero cell-derived) in Avian Influenza (AI), influenza, sponsored by Resilience Government Services. Started May 2009; status: completed.
02
Drugs
inactivated influenza vaccine (vero cell-derived)
03
Conditions
Avian Influenza (AI)influenza
Beyond the preview
Go deeper on NCT00895544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00895544.